Jörg Neermann
Director/Board Member at IMMUNIC, INC.
Net worth: 132 000 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Vitt | M | 55 |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | 7 years |
| Christian Sewing | M | 54 | 35 years | |
| Vincent Ossipow | M | 55 |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | 9 years |
| Andreas Muehler | M | 60 |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | 8 years |
| Tamar Howson | F | 75 |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | 5 years |
| Barclay Phillips | M | 61 |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | 5 years |
| Stefan Simon | M | 55 | 8 years | |
| Manfred Gröppel | M | 55 |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | 8 years |
| Jan van den Bossche | M | 45 |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | 4 years |
| Frank Weber | M | 64 | 12 years | |
| John Thain | M | 69 | 6 years | |
| Glenn Whaley | M | 56 | 5 years | |
| Denis Bedoret | M | 43 |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | 4 years |
| Dagmar Valcárcel | M | 58 | 5 years | |
| Norbert Winkeljohann | M | 66 | 6 years | |
| Jessica Breu | F | - | - | |
| Jörg Eigendorf | M | - | 8 years | |
| Sonia Hallen | M | - |
ViCentra BV
 ViCentra BV Electronic Equipment/InstrumentsElectronic Technology ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands.
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | 5 years |
| Alexander von zur Mühlen | M | 49 | 26 years | |
| Rebecca Short | F | 50 | 3 years | |
| Monika Tornsen | F | 45 | 2 years | |
| Gerlinde M. Siebert | F | 57 | 1 years | |
| James von Moltke | M | 55 | 7 years | |
| Michael Schaeffer | M | 56 | 6 years | |
| Julianne Lindemann | M | - |
Efficas Medical Foods & Nutrition LLC
 Efficas Medical Foods & Nutrition LLC BiotechnologyHealth Technology Efficas Medical Foods & Nutrition LLC develops science-based consumer products for the nutritional management of the immune system for both humans and pets. Its products are non-prescription medical food and helps to provide relief from asthma and associated allergies. The company was founded by Nancy Fogg-Johnson and Alex Merolli in 2003 and is headquartered in Fullerton, CA. | - |
| Mayree Clark | F | 67 | 6 years | |
| Alexander Rijn Wynaendts | M | 63 | 2 years | |
| Bernd Leukert | M | 57 | 5 years | |
| Frank Witter | M | 65 | 3 years | |
| Theodor Weimer | M | 65 | 4 years | |
| Michele Trogni | F | 59 | 6 years | |
| Duane Nash | M | 53 |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | 5 years |
| Sigmar Gabriel | M | 64 | 4 years | |
| Yngve Slyngstad | M | 62 | 2 years | |
| Carlo Künnemann | M | - |
IDEA AG
 IDEA AG Pharmaceuticals: MajorHealth Technology IDEA AG develops pain therapeutics and biopharmaceutical drugs. The firm develops and commercializes non-invasive therapeutic drugs and the targeted pain therapeutics for arthritic and osteoporosis-related inflammation, chronic pain and diseases. Its technology platform is based on proprietary carriers applied on skin and engineered to diminish side effects and increase drug potency. The company founded by Gregor Cevc in 1993 and is headquartered in Munich, Germany. | - |
| Frank Schulze | M | 56 | 1 years | |
| Luis Mendes | M | - | 19 years | |
| Jürgen Tögel | M | 56 | 1 years | |
| Amy Huynh | F | - | 3 years | |
| Volker Steuer | M | - | 1 years | |
| Anke Hallmann | F | - | 11 years | |
| Johannes Stiber | M | - | 12 years | |
| Stephan Szukalski | M | 57 | 11 years | |
| Manja Eifert | F | 53 | 2 years | |
| Olaf van Tuijl | M | - | - | |
| Garrett Neubart | M | - | 18 years | |
| Claudia Fieber | F | 58 | 1 years | |
| Olivier Vigneron | M | 53 | 2 years | |
| Beaux Pontak | M | - | 19 years | |
| Dilip Khandelwal | M | 80 | 5 years | |
| Fabrizio Campelli | M | 51 | 20 years | |
| Zafar Aziz | M | - | 18 years | |
| Susanne Bleidt | F | 57 | 1 years | |
| Sebastian Jost | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hugo Banziger | M | 68 | 16 years | |
| Karl von Rohr | M | 58 | 26 years | |
| Christian Klaus Ricken | M | 58 | 20 years | |
| Karin Dohm | F | 51 | 9 years | |
| Ulrich Dauer | M | 59 |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | 5 years |
| Jürgen Fitschen | M | 75 | 15 years | |
| Anshu Jain | M | 61 | 20 years | |
| Pierre Vandepapeliere | M | - |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | 4 years |
| Marcus Schenck | M | 58 | 3 years | |
| Stefan Viertel | M | 60 | 27 years | |
| Joachim Müller | M | - | - | |
| Hanns-Peter Storr | M | 64 | 22 years | |
| Reginald Cash | M | - | - | |
| Stefan Krause | M | 61 | 7 years | |
| Henry Ritchotte | M | 60 | 20 years | |
| Bennett Macdougall | M | 53 | 10 years | |
| Michael Reuther | M | 65 | 9 years | |
| Sabine Irrgang | F | 62 | - | |
| John A. Goodey | M | 51 | 12 years | |
| Emmanuel DeSousa | M | 57 | - | |
| Jörg Oliveri del Castillo-Schulz | M | 56 | 14 years | |
| Al Tarasiuk | M | - | 4 years | |
| Ludwig Blomeyer-Bartenstein | M | 67 | 41 years | |
| Kabir Dev Masson | M | 44 | 4 years | |
| Kimberly L. Hammonds | F | 56 | 5 years | |
| Nadine Farida Faruque | F | 63 | 2 years | |
| Garth Ritchie | M | 56 | - | |
| Christof von Dryander | M | - | 5 years | |
| Theo Siegert | M | 77 | 6 years | |
| Michael Dobson | M | 72 | 4 years | |
| Richard Henry Meddings | M | 66 | 4 years | |
| Karl-Gerhard Eick | M | 70 | 9 years | |
| Clemens A. H. Börsig | M | 74 | 13 years | |
| Kevin Sullivan | M | 70 | 32 years | |
| Karin Ruck | F | 59 | 29 years | |
| Klaus Rüdiger Trützschler | M | 75 | 5 years | |
| Thorsten Demel | M | - | - | |
| George Donald Johnston | M | - | 11 years | |
| William Michael Cohrs | M | 68 | 15 years | |
| Stephan Leithner | M | 58 | 15 years | |
| Ravi Sachdev | M | 47 | 3 years | |
| Marlehn Thieme | F | 67 | 25 years | |
| Klemens Breuer | M | 56 | 9 years | |
| Peter J. Job | M | 81 | 10 years | |
| Thorsten Strauss | M | 57 | - | |
| Saurav Sen | M | - | 22 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 93 | 93.00% |
| Germany | 12 | 12.00% |
| Belgium | 2 | 2.00% |
| Netherlands | 1 | 1.00% |
| Switzerland | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jörg Neermann
- Personal Network
